Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Holdings
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

AUXILIUM PHARMACEUTICALS INC (AUXL)

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsDec-31-13Dec-31-12Dec-31-11Dec-31-10Dec-31-09Dec-31-08Dec-31-07Dec-31-06
   10-K10-K10-K10-K10-K10-K10-K10-K
Revenues  400.7395.3264.3211.4164.0125.495.768.5
            Revenue growth  1.4%49.5%25.0%28.9%30.8%31.0%39.8%60.0%
Cost of goods sold  112.078.355.749.737.129.524.617.7
Gross profit  288.7316.9208.7161.7127.095.971.150.8
            Gross margin  72.0%80.2%78.9%76.5%77.4%76.5%74.3%74.2%
Selling, general and administrative  250.2185.5179.9164.7129.289.572.861.3
Research and development  50.245.961.948.051.454.542.837.9
Other operating expenses  56.4       
EBITDA   [+]-12.2103.6-25.2-45.1-49.6-45.9-43.0-47.3
            EBITDA margin  -3.1%26.2%-9.5%-21.3%-30.2%-36.6%-45.0%-69.1%
Depreciation  10.918.18.05.94.12.21.41.1
EBITA  -23.185.5-33.2-51.0-53.6-48.1-44.4-48.4
            EBITA margin  -5.8%21.6%-12.6%-24.1%-32.7%-38.4%-46.4%-70.6%
Amortization of intangibles  45.0       
EBIT   [+]-68.185.5-33.2-51.0-53.6-48.1-44.4-48.4
            EBIT margin  -17.0%21.6%-12.6%-24.1%-32.7%-38.4%-46.4%-70.6%
Interest expense, net   [+]28.70.00.20.3-0.2-1.8-3.7-2.4
Other income (expense), net   [+]0.40.50.551.2   0.0
Pre-tax income  -96.485.9-32.90.0-53.5-46.3-40.7-45.9
Income taxes  -78.30.00.00.00.00.00.00.0
            Tax rate  81.3%0.0%0.0% 0.0%0.0%0.0%0.0%
Net income  -18.185.9-32.9-51.2-53.5-46.3-40.7-45.9
            Net margin  -4.5%21.7%-12.5%-24.2%-32.6%-36.9%-42.5%-67.1%
   
Basic EPS   [+]($0.37)$1.76($0.69)($1.08)($1.22)($1.12)($1.07)($1.48)
Diluted EPS   [+]($0.37)$1.74($0.69)($1.08)($1.22)($1.12)($1.07)($1.48)
   
Shares outstanding (basic)   [+]49.348.847.947.443.741.338.231.0
Shares outstanding (diluted)   [+]49.349.347.947.443.841.338.231.0
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy